Dual administration of liraglutide and ghrelin recovers brain mitochondrial energy metabolism in the R6/2 mouse for Huntington's disease

被引:0
|
作者
Mena, Debora [1 ,2 ]
Alves, Ines N. [1 ,2 ]
Sjogren, Marie [3 ]
Oliveira, Catarina R. [1 ,4 ]
Moreira, Paula I. [1 ,5 ]
Bjorkqvist, Maria [3 ]
Duarte, Ana I. [1 ,6 ]
机构
[1] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal
[2] Univ Coimbra, Fac Sci & Technol, Life Sci Dept, Coimbra, Portugal
[3] Lund Univ, Dept Expt Med Sci, Wallenberg Neurosci Ctr, Brain Dis Biomarker Unit, Lund, Sweden
[4] Univ Coimbra, Lab Biochem, Fac Med, Coimbra, Portugal
[5] Univ Coimbra, Lab Physiol, Fac Med, Coimbra, Portugal
[6] Univ Coimbra, Inst Interdisciplinary Res IIIUC, Coimbra, Portugal
基金
瑞典研究理事会;
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P029-T
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [21] Cardiac dysfunction in the R6/2 mouse model of Huntington's disease
    Mihm, Michael J.
    Amann, Deborah M.
    Schanbacher, Brandon L.
    Altschuld, Ruth A.
    Bauer, John Anthony
    Hoyt, Karl R.
    NEUROBIOLOGY OF DISEASE, 2007, 25 (02) : 297 - 308
  • [22] Increased thirst and drinking in Huntington's disease and the R6/2 mouse
    Wood, Nigel I.
    Goodman, Anna O. G.
    van der Burg, Jorien M. M.
    Gazeau, Veronique
    Brundin, Patrik
    Bjorkqvist, Maria
    Petersen, Asa
    Tabrizi, Sarah J.
    Barker, Roger A.
    Morton, A. Jennifer
    BRAIN RESEARCH BULLETIN, 2008, 76 (1-2) : 70 - 79
  • [23] Brain Diffusivity and Structural Changes in the R6/2 Mouse Model of Huntington Disease
    Vorisek, Ivan
    Syka, Michael
    Vargova, Lydia
    JOURNAL OF NEUROSCIENCE RESEARCH, 2017, 95 (07) : 1474 - 1484
  • [24] Mitochondrial calcium uptake capacity as a therapeutic target in the R6/2 mouse model of Huntington's disease
    Perry, Giselle M.
    Tallaksen-Greene, Sara
    Kumar, Ashish
    Heng, Mary Y.
    Kneynsberg, Andrew
    van Groen, Thomas
    Detloff, Peter J.
    Albin, Roger L.
    Lesort, Mathieu
    HUMAN MOLECULAR GENETICS, 2010, 19 (17) : 3354 - 3371
  • [25] Integrative Characterization of the R6/2 Mouse Model of Huntington's Disease Reveals Dysfunctional Astrocyte Metabolism
    Skotte, Niels H.
    Andersen, Jens V.
    Santos, Alberto
    Aldana, Blanca I.
    Willert, Cecilie W.
    Norremolle, Anne
    Waagepetersen, Helle S.
    Nielsen, Michael L.
    CELL REPORTS, 2018, 23 (07): : 2211 - 2224
  • [26] R6/2 Huntington's Disease Mice Develop Early and Progressive Abnormal Brain Metabolism and Seizures
    Cepeda-Prado, Efrain
    Popp, Susanna
    Khan, Usman
    Stefanov, Dimitre
    Rodriguez, Jorge
    Menalled, Liliana B.
    Dow-Edwards, Diana
    Small, Scott A.
    Moreno, Herman
    JOURNAL OF NEUROSCIENCE, 2012, 32 (19): : 6456 - 6467
  • [27] Limbic neurogenesis/plasticity in the R6/2 mouse model of Huntington's disease
    Phillips, Wendy
    Morton, A. Jennifer
    Barker, Roger A.
    NEUROREPORT, 2006, 17 (15) : 1623 - 1627
  • [28] Multiplatform metabolomic analysis of the R6/2 mouse model of Huntington's disease
    Hashimoto, Masayo
    Watanabe, Kenichi
    Miyoshi, Kan
    Koyanagi, Yukako
    Tadano, Jun
    Miyawaki, Izuru
    FEBS OPEN BIO, 2021, 11 (10): : 2807 - 2818
  • [29] Neuroprotective Effects of Doxycycline in the R6/2 Mouse Model of Huntington's Disease
    Paldino, Emanuela
    Balducci, Claudia
    La Vitola, Pietro
    Artioli, Luisa
    D'Angelo, Vincenza
    Giampa, Carmela
    Artuso, Vladimiro
    Forloni, Gianluigi
    Fusco, Francesca R.
    MOLECULAR NEUROBIOLOGY, 2020, 57 (04) : 1889 - 1903
  • [30] Disrupted Temporal Control in the R6/2 Mouse Model of Huntington's Disease
    Balci, Fuat
    Day, Mark
    Rooney, Aislinn
    Brunner, Dam
    BEHAVIORAL NEUROSCIENCE, 2009, 123 (06) : 1353 - 1358